ORAI3 and neoplasm: In some prostate cancers, disease progression seems to be associated with a switch from ORAI1-mediated Ca2+ influx to Ca2+ influx mediated by an ORAI1/ORAI3 heteromeric channel, due to genomic alterations in ORAI3 expression and/or tumor microenvironmental factors [26].